a methodology for using physiologically based pharmacokinetic ( pbpk ) models to derive predicted safe concentrations of noncarcinogens in drinking water for humans based on experimentally determined no observed adverse effect levels ( noaels ) in animals is presented and applied to the case of 1,1,1-trichloroethane ( methyl chloroform , mc ) .
C0040904
trichloroethane
C0043697
methyl chloroform